Study: NCT06681441

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: QRL-101 Dose A
Description: All participants will receive three single-dose oral administrations in randomized order, scheduled across three separate study visits, with a 7-day washout period between each visit.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: QRL-101 Dose A
Description: All participants will receive three single-dose oral administrations in randomized order, scheduled across three separate study visits, with a 7-day washout period between each visit.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: QRL-101 Dose A
Description: All participants will receive three single-dose oral administrations in randomized order, scheduled across three separate study visits, with a 7-day washout period between each visit.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: QRL-101 Dose A
Description: All participants will receive three single-dose oral administrations in randomized order, scheduled across three separate study visits, with a 7-day washout period between each visit.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: QRL-101 Dose A
Description: All participants will receive three single-dose oral administrations in randomized order, scheduled across three separate study visits, with a 7-day washout period between each visit.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: QRL-101 Dose A
Description: All participants will receive three single-dose oral administrations in randomized order, scheduled across three separate study visits, with a 7-day washout period between each visit.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: QRL-101 Dose B
Description: All participants will receive three single-dose oral administrations in randomized order, scheduled across three separate study visits, with a 7-day washout period between each visit.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: QRL-101 Dose B
Description: All participants will receive three single-dose oral administrations in randomized order, scheduled across three separate study visits, with a 7-day washout period between each visit.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: QRL-101 Dose B
Description: All participants will receive three single-dose oral administrations in randomized order, scheduled across three separate study visits, with a 7-day washout period between each visit.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: QRL-101 Dose B
Description: All participants will receive three single-dose oral administrations in randomized order, scheduled across three separate study visits, with a 7-day washout period between each visit.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: QRL-101 Dose B
Description: All participants will receive three single-dose oral administrations in randomized order, scheduled across three separate study visits, with a 7-day washout period between each visit.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: QRL-101 Dose B
Description: All participants will receive three single-dose oral administrations in randomized order, scheduled across three separate study visits, with a 7-day washout period between each visit.